17
Nov

In what will likely be the most closely watched IPO in biotech, Juno Therapeutics has rolled out a $150 million offering that is likely to make a big splash on the market.

…read more

Source: Juno takes its hot CAR-T cancer tech to Wall Street in $150M IPO

    

0 No comments